Clinical characteristics of patients with non-<i>V600 BRAF</i> mutant melanomas.
Daewon Kim(Gangneung–Wonju National University), Kevin Kim(The University of Texas MD Anderson Cancer Center), Patrick Hwu(Moffitt Cancer Center), Sapna P. Patel(JSS Dental College and Hospital), Alan Siroy(The University of Texas MD Anderson Cancer Center), Mark J. Routbort(The University of Texas MD Anderson Cancer Center), Michael A. Davies(The University of Texas MD Anderson Cancer Center), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Agop Y. Bedikian(The University of Texas MD Anderson Cancer Center), Kunhwa Kim(The University of Texas MD Anderson Cancer Center), Sasan Nowroozi(The University of Texas MD Anderson Cancer Center), Nicholas E. Papadopoulos(The University of Texas MD Anderson Cancer Center), Scott E. Woodman(The University of Texas MD Anderson Cancer Center), Wen‐Jen Hwu(The University of Texas MD Anderson Cancer Center), Silva Frankian(The University of Texas MD Anderson Cancer Center)
Cited by 4
Related Papers
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
|Cell|2018|2.8k
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
|Cell|2018|2.4k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k